Although fERG improved in AMD patients compared to baseline after treatment with saffron, no significant differences were reported in the CFH (Complement Factor H) or ARMS2 (Age-Related Maculopathy Susceptibility 2) polymorphism genotypes. This evidence concerns the gene ARMS2 and age-related macular degeneration.